Safety

Orencia (abatacept) for injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)  

December 2014

Summary View

WARNINGS AND PRECAUTIONS

Hypersensitivity
  • In clinical trials of 2688 adult RA patients treated with intravenous Orencia, there were two cases (<0.1%) of anaphylaxis or anaphylactoid reactions…
     

 

February 2012

Summary View

Warnings and Precautions

  • to include information regarding serious infections.

 

Page Last Updated: 01/15/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.